**Core Concept**
The patient is experiencing extrapyramidal side effects such as seizures and agranulocytosis, which are associated with the use of typical antipsychotic agents. These agents work by blocking dopamine receptors in the brain, particularly D2 receptors, which are involved in the regulation of motor function and other physiological processes.

**Why the Correct Answer is Right**
The antipsychotic agent is likely to be a typical antipsychotic, such as chlorpromazine or haloperidol, which are known to cause seizures and agranulocytosis as side effects. These agents block dopamine receptors, leading to an increase in dopamine release in the nigrostriatal pathway, which can cause extrapyramidal symptoms. Additionally, the blockade of dopamine receptors in the bone marrow can lead to agranulocytosis.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is not provided.
**Option B:** Atypical antipsychotics, such as risperidone or olanzapine, are less likely to cause seizures and agranulocytosis as side effects. They have a different pharmacological profile, with a higher affinity for serotonin receptors, which reduces the risk of extrapyramidal symptoms.
**Option C:** This option is not provided.
**Option D:** This option is not provided.

**Clinical Pearl / High-Yield Fact**
Typical antipsychotics, such as chlorpromazine and haloperidol, are more likely to cause extrapyramidal side effects, including seizures and agranulocytosis, due to their high affinity for dopamine D2 receptors. Atypical antipsychotics, on the other hand, have a lower risk of these side effects due to their higher affinity for serotonin receptors.

**Correct Answer:** .
(Unfortunately, options A, C, and D were not provided, so I couldn't give a specific answer. If you provide the correct options, I'll be happy to complete the explanation.)